PubMed Health⌕ Search

Biomedical subjects

C E Zanotto

Publications and source records attributed to C E Zanotto.

2 recordsLinked to original sources

Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages.

A double-blind crossover study was performed to evaluate the bronchodilating effect of different single doses of procaterol (less than 0.5 micrograms/kg, 1.5 micrograms/kg, and placebo) orally administered. Sixteen asthmatic children, age 6-12 years, participated in the trial. Pulmonary function, heart rate, blood pressure, and tremor were evaluated at 30, 60, 90, and 120 min and then hourly for 8 hours after administration. All three doses were therapeutically effective. The 1.5 micrograms/kg dose produced a more sustained bronchodilatation effect, but was also associated with an increase in the incidence of tremors. The 0.5 micrograms/kg dosage may, however, be a good starting dose because it assures a reasonable risk/benefit ratio.

Administration, Oral↗

[Bronchial hyperreactivity. I. General concepts].

Bronchial hyperreactivity is a condition in which the airways show a much greater bronchoconstrictor response to provocative stimuli than normal. Non-specific bronchial hyperreactivity is a feature of asthmatic patients both allergic and non-allergic. It is proposed that bronchial hyperreactivity is due to the fact that the airways are narrower. In addition changes in the mass of muscle, and changes in the contractility of the muscle may contribute to bronchial hyperreactivity. Moreover bronchial hyperreactivity could be due to increased alpha-adrenergic or parasympathetic activity or to decreased beta-adrenergic or non adrenergic inhibitory activity. Bronchial hyperreactivity can be induced by factors such as infection, inflammation or exposure to allergens.

Airway Resistance↗